Your browser is outdated!

To ensure you have the best experience and security possible, update your browser. Update now

×

Warren Lammert

Warren Lammert

Financial Executive- Granite Point Capital

Boston United States (Massachusetts)
Employed Available
Warren Lammert is the Founder and CIO Granite Point Capital, a public/private investment firm started in 2004 and located in Boston. Warren began his career in finance as a research associate with Fred Alger Management in New York City in 1984 and has over 35 years of investment experience as an analyst and portfolio manager. He is a graduate of Yale University and the London School of Economics where he completed an MSc in Economic History with Distinction. He is a CFA® charter holder.

Warren has worked to support new therapies in epilepsy over the last twenty five years. He is the co-founder of Epilepsy.com and the Epilepsy Therapy Project and is a past chairman of the Epilepsy Foundation. In recent years, Warren has served in board roles with companies developing new therapies for epilepsy including Biscayne Neurotherapeutics (acquired by Supernus Pharma in 2018), Engage Therapeutics (acquired by UCB in 2020), and Cerebral Therapeutics where he served as board chair. He is also on the board of Receptor Therapeutics which is advancing new therapies to treat anxiety. He is also a co-founder and the chairman of Tevard Biosciences, a company developing gene therapies for Dravet syndrome and other rare disorders.

Warren’s interests include Chinese language, European and Chinese economic history, ice-hockey, squash and running.
Resume created on DoYouBuzz

Co-Founder, Chairman

Tevard Biosciences
Since October 2017

Member Board of Directors

Engage Therapeutics
Since December 2017

Chairman

Cerebral Therapeutics
Since June 2018